Novosanis

medical devices

About

Novosanis is a Belgian medical device company that develops user-friendly devices to enhance the accuracy and standardization of diagnostic tests and drug delivery. Founded in March 2013 as a spin-off from the University of Antwerp, the company focuses on solutions for infectious diseases and oncology, utilizing non-invasive sampling methods to improve prevention, detection, and treatment. The flagship product, Colli-Pee™, is an award-winning urine collection device designed to standardize the collection of first-void urine, which is crucial for detecting biomarkers related to infectious diseases and early-stage cancers. Its innovative design captures the initial urine while allowing excess fluid to pass into the toilet, ensuring sample accuracy. Novosanis is ISO 13485 certified, demonstrating its commitment to quality in medical device manufacturing. The company primarily serves healthcare providers, diagnostic laboratories, and pharmaceutical companies, aiming to enhance user comfort and reliability in sample collection and drug administration.

Technologies

Outlook Pardot Microsoft Office 365 Google Cloud Hosting Drupal Google Font API Nginx YouTube Google Tag Manager Mobile Friendly AI

Keywords

medical device in vitro diagnostics vaccination urine collection firstvoid urine collection intradermal vaccination infectious diseases collipee vaxid oncology diagnostics medical equipment manufacturing medical device support legal manufacturer change diagnostic tests oncology diagnostics medical equipment and supplies manufacturing colli-pee device diagnostics industry diagnostic device development product labeling sample collection devices diagnostic sample collection device subsidiary of orasure product manufacturing medical device manufacturing molecular diagnostics subsidiary manufacturing medical device development colli-pee

Location

500 Palladium Drive, Ottawa, Ontario, Canada, K2V 1C2

Related Companies

Companies in the same industry